Table 1.

Baseline characteristics of the 332 HIV-infected children initiating ART and followed-up at the CePReF between 2004 – 2009, Abidjan, Côte d’Ivoire.

		Overall	< 2 years	2 – 3 years	3 – 5 years	5 – 10 years	> 10 years
		N = 332	N = 62	N = 34	N = 52	N = 109	N = 75
Age, years, median (IQR)		5.7 (2.6 – 9.3)	1.3 (0.9 – 1.8)	2.5 (2.2 – 2.7)	4.0 (3.6 – 4.5)	7.1 (6.3 – 8.4)	12.2 (11.0 – 14.3)
Male,n (%)		182 (54.8)	34 (54.8)	21 (61.8)	33 (63.5)	49 (45.0)	45 (60.0)
CD4 cell % median (IQR)		10.5 (5.8 – 13.9)	14.3 (10.2 – 17.7)	12.5 (7.8 – 14.2)	10.9 (6.3 – 13.5)	8.4 (2.2 – 12.4)	8 (3.6 – 12.9)
CD4 count/µL,median (IQR)		293 (96 – 614)	785 (518 – 1070)	587 (403 – 1082)	394 (220 – 603)	162 (33 – 333))	135 (33 – 273)
Imunnodeficient* children, n (%)		217 (65.4)	62 (100.0)	32 (94.1)	12 (23.1)	60 (55.1)	51 (68.0)
CDC Stage C		96 (29.1)	19 (31.2)	8 (2.35)	14 (26.9)	26 (24.1)	29 (38.7)
Cotrimoxazole prophylaxis, n (%)		332 (100.0)	62 (100.0)	33 (97.1)	51 (98.1)	108 (99.1)	75 (100.0)
Antiretroviral regimen
NNRTI		255 (77.3)	38 (61.3)	15 (44.1)	39 (75.0)	93 (86.9)	70 (93.3)
PI		75 (22.7)	24 (38.7)	19 (55.8)	13 (25.0)	14 (13.1)	5 (6.7)
Principal caregiver. n (%)
Mother alone		65 (19.6)	13 (21.0)	9 (26.5)	11 (21.2)	23 (21.1)	9 (12.0)
Father alone		33 (9.9)	3 (4.8)	5 (14.7)	3 (5.8)	15 (13.8)	7 (9.3)
Both parents		129 (38.7)	39 (62.9)	17 (50.0)	34 (65.4)	26 (23.9)	13 (17.3)
Other		105 (39.2)	7 (11.3)	3 (8.8)	4 (7.7)	45 (41.3)	46 (44.2)
Distance from clinic, n(%)
< 5 kms		186 (56.0)	45 (72.6)	19 (55.9)	32 (61.5)	50 (45.9)	40 (53.3)
5 – 20 kms		67 (20.2)	8 (12.9)	9 (26.5)	8 (15.4)	19 (17.4)	23 (30.7)
> 20 kms		79 (23.8)	9 (14.5)	6 (17.7)	12 (15.2)	40 (36.7)	12 (16.0)

^*According the 2006 WHO definitions